The Dangers of a Popular Asthma Drug
Xolair, the brand name for Omalizumab, is a drug manufactured by Genentech and Novartis to treat moderate to severe asthma, chronic idiopathic urticaria, and nasal polyps. It functions by reducing the amount of IgE (Immunoglobulin E) in the body that can cause an allergic reaction known as anaphylaxis.
Despite being approved by the FDA, Xolair had been linked to several severe side effects that initiated a number of lawsuits. Side effects included heart attacks, strokes, blood clots, cancer, and severe allergic reactions, among others. Plaintiffs claimed that the manufacturers failed to warn the public and the medical community about these potential risks, thereby violating their duty of care to consumers. Most notably, Xolair was linked to an increased risk of cardiovascular and cerebrovascular adverse events.
Updated Labeling of Xolair
A FDA review in 2014 prompted a label change to reflect these risks. The updated labeling now includes a description of these risks in the "Warnings and Precautions" section, stating that patients using Xolair should be monitored for signs of these conditions.
Furthermore, some lawsuits alleged that Xolair could increase the risk of certain types of cancer, such as skin, prostate, and breast cancer. Plaintiffs claimed the manufacturers were aware of these risks but did not adequately warn healthcare providers or patients, leading to allegations of negligence and concealment.
One of the crucial points in these lawsuits is that the plaintiffs argued the manufacturers had a duty to warn patients and healthcare providers about the risks associated with Xolair. It's alleged that they failed to adequately provide these warnings, thus violating this duty and contributing to the harm suffered by the plaintiffs.
Genentech and Novartis Face Xolair Lawsuits
A significant number of these cases are now pending in courts across the United States. The lawsuits could potentially result in substantial financial settlements for Genentech and Novartis, not to mention the reputational damage that could result from these cases.
However, it's essential to note that while these lawsuits raise serious concerns about Xolair, they do not necessarily prove the drug's dangers. The courts will ultimately decide on the merits of these claims based on the evidence presented.
Medical Record Reviews Strengthen Xolair Lawsuits
Central to the Xolair lawsuits is the comprehensive review of medical records. This critical process helps to establish a precise timeline of events, calculate the administered dosage and frequency of Xolair, recognize any pre-existing conditions that could have exacerbated the adverse effects, and illustrate the causal relationship between the use of Xolair and the injuries endured.
These reviews necessitate the expertise of both legal professionals and medical practitioners to ensure an accurate understanding of medical terminologies, procedures, and outcomes involved. Therefore, if you or someone close to you has been negatively impacted by Xolair, it's advisable to explore your legal options. To strengthen your case, seek the assistance of top-rated medical record review services.